Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Inari Medical, Inc. (NARI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2023 |
8-K
| Quarterly results|
Docs:
|
"Consolidated Statements of Operations and Comprehensive Income Three Months Ended December 31, Years Ended December 31, 2022 2021 2022 2021 Revenue $ 107,771 $ 83,218 $ 383,471 $ 276,984 Cost of goods sold 13,128 8,280 44,506 24,757 Gross profit 94,643 74,938 338,965 252,227 Operating expenses Research and development 20,412 18,726 74,221 51,018 Selling, general and administrative 80,122 54,466 292,843 190,365 Total operating expenses 100,534 73,192 367,064 241,383 income from operations 1,746 10,844 Other income Interest income 970 24 1,852 154 Interest expense Change in fair value of warrant liabilities — — — — Other income 187 356 Total other income 1,083 1,914 income before income taxes 1,681 10,685 Provision for income taxes 990 574 3,082 845 Net income $ $ 1,107 $ $ 9,840 Other c..." |
|
| 08/03/2022 |
8-K
| Quarterly results |
| 05/04/2022 |
8-K
| Quarterly results |
| 02/23/2022 |
8-K
| Quarterly results|
Docs:
|
"Consolidated Statements of Operations and Comprehensive Income Three Months Ended December 31, Years Ended December 31, 2021 2020 2021 2020 Revenue $ 83,218 $ 48,610 $ 276,984 $ 139,670 Cost of goods sold 8,280 3,685 24,757 13,106 Gross profit 74,938 44,925 252,227 126,564 Operating expenses Research and development 18,726 6,536 51,018 18,399 Selling, general and administrative 54,466 31,393 190,365 89,746 Total operating expenses 73,192 37,929 241,383 108,145 Income from operations 1,746 6,996 10,844 18,419 Other income 0 Interest income 24 75 154 484 Interest expense Change in fair value of warrant liabilities — — — Other expense, net Total other expenses Income before income taxes 1,681 6,985 10,685 13,789 Provision for income taxes 574 — 845 — Net income $ 1,107 $ 6,985 $ 9,840 ..." |
|
| 11/09/2021 |
8-K
| Quarterly results|
Docs:
|
"Condensed Consolidated Statements of Operations and Comprehensive Income Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenue $ 72,916 $ 38,715 $ 193,766 $ 91,059 Cost of goods sold 7,040 3,228 16,477 9,420 Gross profit 65,876 35,487 177,289 81,639 Operating expenses Research and development 12,499 5,217 32,292 11,863 Selling, general and administrative 56,104 23,080 135,899 58,353 Total operating expenses 68,603 28,297 168,191 70,216 income from operations 7,190 9,098 11,423 Other income Interest income 27 208 130 409 Interest expense Change in fair value of warrant liabilities — — — Other income 30 Total other expenses income before income taxes 6,496 9,004 6,804 Provision for income taxes 61 — 271 — Net income $ $ 6,496 $ 8,733 $ 6,804 Other..." |
|
| 08/10/2021 |
8-K
| Quarterly results |
| 05/11/2021 |
8-K
| Quarterly results |
| 11/12/2020 |
8-K
| Quarterly results |
| 08/11/2020 |
8-K
| Quarterly results |
|
|